UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Endocyte is implementing good security practices.
Endocyte (NASDAQ: ECYT) is a biopharmaceutical company established in 1996 and headquartered in West Lafayette, Indiana, a resident of the Purdue Research Park. In 2011 the company completed successfully an initial public offering (IPO).
This report shows a preliminary security rating for Endocyte. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
Today, cybersecurity and vendor risk management are a top priority not only for CISOs but senior ...
A vendor risk management questionnaire (also known as a third-party risk assessment questionnaire ...
Compare Endocyte's security performance with other companies